Bio

Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world’s first platform to enable any community to leverage cutting- edge biotechnology to advance understanding of any rare disease. Partnering with top medical institutions, RGI helps custom design personalized research projects for rare diseases. Dr. Lin is also the Director of Clinical Genomics at the Genetics Branch of the National Institute of Health/National Cancer Institute (NIH/NCI). Prior to this, he led the computational analysis of the first ever exome sequencing studies for any human disease at Johns Hopkins and was a research instructor at Washington University in St. Louis. He has numerous publications in Science, Nature, Cell, Nature Genetics, and Nature Biotechnology, and has been featured in Forbes, Bloomberg, Wall Street Journal, Washington Post, BBC, TIME, and the Huffington Post.

Researcher

Dr. Lin has published over 100+ papers, book chapters, and abstracts including top academic journals such as Science, Nature, and Cell and has spoken at top universities such as Harvard, Yale, and Stanford.

Speaker

Dr. Lin has delivered over 100+ keynotes, speeches, and panels in 19 countries on 5 continents, including TED, Aspen Ideas Festival, Google, the White House and the European Commission.

Thought Leader

Dr. Lin has been featured or mentioned in over 300+ media outlets including New York Times, Washington Post, CNN, Financial Times, Forbes, BBC, WIRED and TIME.